News
Hosted on MSN6mon
RARE's Bone Disorder Drug Gets FDA's Breakthrough Therapy TagSetrusumab, a fully human monoclonal antibody, is an inhibitor of the sclerostin protein ... that speeds up the development and review of drugs for serious or life-threatening conditions.
Evenity is the first sclerostin inhibitor to be approved for osteoporosis ... risk of fractures than alendronic acid alone" and the drug is now considered cost effective when used according ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results